chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood in urine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Jul2022 at 15:00 as dose 3 (booster), single (Lot number: FP7137) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "NHL Lymphoma" (unspecified if ongoing); "CVID" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Covid-19" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer Biontech, Prev dose brand unknown=False, Prev dose lot unknown=True, Prev dose lot unknown reason=Unable to locate or read the details, Prev dose administration time=12:00 AM, Prev dose number=2, Prev dose vaccine location=Left arm), administration date: 28Apr2021, when the patient was 63-year-old, for COVID-19 immunization; BNT162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer Biontech, Prev dose brand unknown=False, Prev dose lot number=EW0151, Prev dose lot unknown=False, Prev dose administration time=12:00 AM, Prev dose number=1, Prev dose vaccine location=Left arm), administration date: 07Apr2021, when the patient was 63-year-old, for Covid-19 immunization. The following information was reported: BLOOD URINE PRESENT (medically significant) with onset 29Jul2022 at 19:00, outcome "unknown", described as "Blood in urine". The event "blood in urine" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood urine present: (29Jul2022) Blood in urine. It was unknown if therapeutic measures were taken as a result of blood urine present. The patient did not receive any other vaccines within four weeks prior to the vaccination. Other medications in two weeks were too long to list. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Became blind after receiving Johnson & Johnson vaccine and now has  been said to be Blind-Function Neurological.
Left Upper Extremity Numbness Narrative:  1- My left arm (arm I received the vaccine in) got pins and needles feeling in it about 1 hour post vaccine, and it continued through the evening as well as in my legs, forehead, and upper cheeks on my face. Best way to explain it is that feeling you get when your arm falls asleep and is waking up. I've spoke to a few others who had similar feeling in their vaccine arm.
Patient started to have trouble breathing around February 10th. She also complained that she couldn't swallow very well since the 2nd vaccine on February 2nd.  On February 12 she called in a panic.  Her lips were swollen and then her tongue started to swell. I took her to the ER where they sent us to a large hospital.  They ran all sorts of test.  Blood work, CT Scan, ultra sound. No one could tell me why this was happening.  They gave her antibiotics and steroids and the following morning on February 13th she was discharged.   The next morning on February 14, patient called me again in a panic. She couldn't breath and couldn't swallow. Her lips, tongue, and under her chin were swollen, hot, and hard as a rock.  I rushed to get her and took her back to the hospital. She was in the ER for about 8 hours where she was almost intubated as her airway was close to closing off.  She was moved up to the ICU that day and stayed in the the ICU until February 19th.  During that time, they ran all the same tests, blood work, CT Scan, ultrasound and no one could tell me why my mom was having this reaction.    After we returned home I received a call from the ICU doctor who was checking on her as they had more patients come in with the same symptoms post covid - vaccine.  She advised to file this reaction with all the information I had and told me that patient was not to get the booster if one was required later.
Presented to school based health center approx 2 hours after receiving Tdap - Varicella vaccinations with c/o skin rash itching on face, arms, trunk, face flushed pulse 76/min. Resp 18 BP 118/66 temp 97.2 - macular rash on trunk, Fine red papular rash on arms - No hives observed.
At 2 months of age, patient received these immunizations. That evening he was groggy but woke several times with a high pitched cry. For 8-10 days he would periodically cry with an uncharacteristic cry and was not his normal smiling self.
Started with Right hip pain Moved to right side and Right knee, then to groin and into Left back pain. Whole body muscle spasms.
Full body hives, swollen, itching.  Started on arms and spread to trunk, groin, thighs. Scattered spots on feet and face. Lasted for 24hrs. Then, most areas improved except for right arm.  Huge patches of hives, swollen, warm, itchinf.
Patient reports having a sharp pain in the upper thigh following exercise. The pain was the most intense the day it happened. Patient stated " It feels like a pulled muscle". Patient stated that it only hurts when he moves a certain way. Call was transfered to a provider for further assessment. Provider advised that the patient continues to have the pain or if the pain worsens to call 911 or go to the nearest emergency room. Patient also educated on other signs and syptoms to look out for and when to seek medical attention.
The evening after the COVID-19 booster vaccine, began to have nausea and vomiting. Later developed fatigue, dehydration, fever, chills, and chest pain and shortness of breath. No cough. Symptoms progressed over next 36 hours until had video visit with primary care office who recommended ER evaluation on 10/31.
Day after shot had mild swelling & tenderness at site. 3 days after shot, had developed approx. 6 inch x 6 inch erythema/swelling & itching. Located a few inches distal to the injection site.
210 am woke up hot. Walked downstairs had ringing in my ear and saw stars, held the wall almost passed out. Began profusely sweating drenching my clothes. Nausea began. Went back upstairs sat on my bathroom floor due to nausea/ dry heave. All of a sudden SEVERE abdominal pain began 10/10. Cried for my husband. Dripping sweat gave me a cold rag and foam large diarrhea began. Still 10/10 pain in abdomen. Felt like my lower abdomen was getting ripped out.  About 45 minutes or so later still 10/10 wanted to go to ER. I could not stand. If I stood my legs and body felt like I wanted to curl in a ball on the floor. He called an ambulance. I was pale as a ghost, no fever, normal vital signs. Went into full reynauds flare from body stress. Ambulance was unable to get oxygen sat and glucose at the time due to flare. Arrived at the ER labs drawn. WBC 10.9 and Glucose 194. I am not or never have been diabetic. Vaccine related. Like a lightswitch all symptoms stopped except sweating hot and cold spells, sore arm and drowsiness. Discharged at 6am
6 days p/vax pt c/o severe h/a, n/v, fever;taken from MD office by amb to hosp;dx viral meningitis;pt sent home to wait out disease process;
Pt to ED 9/11  w/ c/o hip dislocation, pt COVID+ 9/10. Pt w/ even and unlabored respirations, AOx0 w/ response to painful stimuli. 9/12 pt is very uncooperative with care, to OR for Revision to a total hip arthroplasty. Post-surgery, pt is alert and oriented to 0. Not following commands, on room air. Pt discharged 9/14.
dizziness, headache, back pain that began 3-4 hours after vaccine. Symptoms lasted for 2 days. Patient states symptoms will last on and off a few minutes at a time.
NEEDLE-LIKE PAIN ON SIDES OF NECK; NEEDLE-LIKE PAIN IN CALF AREA OF FRONT AND BACK OF BOTH LEGS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included hypertension, and concurrent conditions included iodine allergy, and shellfish allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043121A, and batch number: 043121A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-APR-2021, the subject experienced needle-like pain in calf area of front and back of both legs. On 18-APR-2021, the subject experienced needle-like pain on sides of neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from needle-like pain in calf area of front and back of both legs, and needle-like pain on sides of neck. This report was non-serious.
Redness, swelling, itchiness at injection site (left deltoid) that began 7 days after injection
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2014, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 23-DEC-2015, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
I experienced swelling in my hands/Swelling calves; Swelling face; Swelling ankles; the next day I started feeling a slight burning sensation; Feeling itching that continued for the next 2 1/2+ weeks; Approximately 4-5 hrs after injection I started feeling pins & needles throughout my entire body; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 61-years-old non pregnant female non pregnant patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: ER8729), via an unspecified route of administration, administered in Arm Left on 23Jul2021 09:30 (at the age of: 61-years-old) as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, asthma, Sulfa drugs allergy and shellfish allergy. Concomitant medications included levothyroxine, liothyronine (NP THYROID), senna acutifolia (SENNA ACUTIFOLIA), vitamin d3 (VITAMIN D3), probiotics (PROBIOTICS) and multi vitamin received 2 weeks prior to the vaccination. The patient previously took amoxicillin and experienced drug hypersensitivity. The patient did not receive any other vaccine within 4 weeks prior to covid vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was reported that approximately 4-5 hrs after injection she started feeling pins & needles throughout her entire body, the next day she started feeling a slight burning sensation as well as itching that continued for the next 2 1/2 plus weeks. Also, she experienced swelling in her hands/face in the a.m. & calves/ankles in the p.m. about 1 week after the shot. The patient did not received treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was recovered/resolved with Sequel.  Follow-up attempts are completed. No further information is expected.
I had a ?COVID arm? appear with a red circle about the size of a half dollar at the sight of the injection. It also itches and is warm to the touch.
This spontaneous report as received from a registered nurse refers to a 63 year old male patient with chronic obstructive pulmonary disease and diabetes mellitus. The patient was first time vaccinated with a pneumococcal vaccine (manufacturer unknown) on 30-SEP-2008. Then on 21-MAY-2015, the patient was re-vaccinated with an expired dose of PNEUMOVAX23 lot # J011045 and expiration date on 15-MAY-2015 (route and dose were not provided). The patient received the second dose of pneumococcal vaccine because of her history of obstructive pulmonary disease and diabetes mellitus. The patient had not demonstrated or reported any adverse effects. Additional information has been requested.
One hour of vaccination, goose-egg swelling at injection site, no pain.   2 hours of vaccination, 101.5° temperature, minor aches.  Overnight (10 hours after vaccination) pain in both outer thighs, muscle spasms in sections of thigh muscles.  Growing pain across lower back.  Pains increase over the next 24 hours to two days.  Respond to ice treatment, but return within 30 minutes of icing outer thighs.  Both sides of body symmetric feel pain, which extends across lower back.   Very difficult to rise from sitting position or rotate while walking, but able to walk.  Iced thighs three or more times per day as needed.   After three weeks pain is now almost completely gone.   Never had an allergenic  other adverse reaction to any vaccination, including prior years receiving Fluzone Multivalent HD.  Within five days begin symptoms to slowly abate
extreme fatigue; temperature of 102.2 Fahrenheit; muscle pain- involving her whole body; chills /shivering; muscle pain that prevented her from sleeping; red patch; This case was reported by a consumer via call center representative and described the occurrence of skin red in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included trigeminal neuralgia (had trigeminal neuralgia which occurred many years ago.).   On 25th January 2020, the patient received the 2nd dose of Shingrix. In January 2020, less than a day after receiving Shingrix, the patient experienced skin red. On 25th January 2020, the patient experienced fatigue, fever, myalgia, chills and sleeplessness. The patient was treated with naproxen. On an unknown date, the outcome of the skin red, fever, myalgia, chills and sleeplessness were recovered/resolved and the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the skin red, fatigue, fever, myalgia, chills and sleeplessness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in her left deltoid. She stated she had a red patch, about 2.5-3 inches, below the injection site, which has resolved. Patient states that same evening she started to experience extreme fatigue, shivering, chills, muscle pain involving her whole body, which prevented her from sleeping, and, she had a temperature of 102.2 Fahrenheit.  The patient took 220 mg naproxen, two tablets every 4-6 hours which helped with the fever.  All the adverse events have resolved except the fatigue. The patient did not remember which she got the 1st dose of the Shingrix. The reporter consented to follow up.
Nausea, vomiting, fatigue - Promethazine 25mg  Q8h x 3 days
Admitted with cough; COVID-19 no pna; tx w/steroids, redemsivir, Vit C, zinc, O2; weaned to RA, discharged home.
This spontaneous report was received from a medical assistant and refers to a 69-year-old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 11-MAR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 lot # L012521 and expiration date 01-FEB-2017 (dose and route of administration were not reported). The vaccine underwent temperature excursion of 1 degree Celsius for 158 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information is not expected as all the data was already obtained.
Fever 101 degrees F starting 4 13 10; 4 14 10 fever went up to 103 degrees F.
pt recv vax 8NOV96 & few days p/vax pt devel hives on forearms, shoulders, chest, back & legs;has no prev hx of allergy to eggs;hives persisted & in JAN97 steroids were prescribed;
Soreness at site of injection. "Nerve pinched". Began to feel sore 7 days, post vax, while she was in Europe. She called me on 1/8/01 to "report" not "complain", she said. She also felt that the injection was given too high on the arm. (She was an RN) Injection was given in the upper deltoid region and still has "intermittent pain".
07/13/2021 during the injection she felt a knot on the right side of her neck, arm got hot, that it until later in the evening it felt like she was feeling like she was catching a cold and had a sore thought like it was scratchy in middle of through sore through moved to middle of chest then to right below lower than breast bone. Went back and forth between those three location. 06/22/2021 - after the vaccination Sight changed vision worsen since the vaccination and has changed her glassed two or three times since the vaccination. Food and liquid is not passing through it feels like it is trapped in her chest.
Large localized swelling, roughly "tennis ball-sized" - developing around 24 hours post injection.
None, patient had a sore arm. She recieved 2nd vaccine 5/19/2021
I got shot (Flu shot) approx 2 pm - started sneezing at 6 pm by 7 pm coughing by 9 pm cold chills at 2 am could not open either eye - washed in warm water - could barely see - like looking thru plastic - 6 am same thing with eyes - for days my eyes were discharging & burning.
Patient described waking up next day (morning) having joint pain, "bone" pains, flu like symptoms, blurred vision and no appetite at all. Also weakness.
Light sensitivity. Kept eyes closed. Didn t go near windows. Could see but light was too bright.
Nothing happened after the first shot. With the second shot I have broken out into hives. The area where I got the shot became feverish and swollen as well.
C/o symptoms starting 1 1/2 hrs after receiving imm. shots. Weird H.A.-felt like a band across the eyes. 3/31 now feeling like a little bit of pressure. Tinnitus, tingling on face, shoulders, upper part of body. Some itching with tingling muscles of face feel slack. Feels blah and spacey.
Pt developed spreading redness, tenderness at injection site (left thigh) and temperature of 101, 15 hours post vax. Diagnosed with cellulitis with good response to antibiotics.
first dose /11th November, 2020; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose of Shingrix received on 11th November 2020.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The male patient received his first dose of Shingrix and She'd like to know how to proceed ,and patient did not received second dose yet which led to incomplete course of vaccination. No vaccine information was provided at the time of the call. No further events were reported at the time of the call. Consented to follow up.
My period, after it seemingly skipping completely after having 2 weeks of pms and spotting and it starting to go away, came extremely suddenly a few days after getting the vaccine. It was must more quick and clotty than it even usually is when I pass a fibroid (family has a genetic history of them, this isn't my first time having one).  The pain was very intense because it was essentially getting itself over with (heaviest bleeding and symptoms for the first 4 days) twice as fast as it normally would. What would usually be an entire day of more spaced out most acute pain was condensed into a more intense half day of even more acute pain. This happened while I was at work before I even passed the fibroid at home (something I had to do via masturbation, aka making my uterus contract via orgasm, which I could not do at work).
No adverse effect; patient recieved MMRII and VARIVAX via intramuscular route; This spontaneous report was received from a health professional (nurse) refers to a patient of unknown age and gender. The patients' pertinent medical history and drug reactions/allergies were not reported. The concomitant therapies included sterile diluent (STERILE DILUENT). On 13-MAY-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength, dose, frequency and anatomical location were unknown) (lot # R014689,expiry date 23-MAY-2020) via intramuscular route for prophylaxis, varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, frequency and anatomical location were unknown) (lot # R031626,expiry date 01-NOV-2020) via intramuscular route for prophylaxis.( incorrect route of product administration). No adverse effects reported. No product quality complaint (PQC) reported for this case.
Itchy Rash on my right side of neck, right arm, all over my stomach and both  legs. Also, itchy face and scalp
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 13-MAY-2013 the patient was vaccinated with the first dose of GARDASIL (dose, route and lot number were not reported). On 16-JUL-2013 the patient received a partial second dose of GARDASIL (dose, route and lot number were not reported) due to a syringe leakage. Concomitant medications were not reported. No adverse symptoms reported. Additional information has been requested.